THURSDAY, NOVEMBER 23, 2017

Phase 3 of sarcoma chemotherapy trial is discontinued

A clinical trial designed to compare three advanced Kaposi’s sarcoma chemotherapy treatment regimens combined with antiretroviral treatment for AIDS patients will not accept any more participants into its oral chemotherapy drug etoposide tests. Read More »

Study shows effectiveness of new HIV therapy drugs on infected children

Louise Kuhn, a professor of epidemiology at Columbia University's Mailman School of Public Health, has been studying the effects of switching HIV therapy drugs after achieving viral suppression. Read More »

Mixed-strain malaria infections affect disease's spread

Emory University scientists recently discovered that the competition between different strains of malaria parasites could affect how drug-resistant malaria spreads throughout humans. Read More »

Memory B cells of HIV patients show affinity maturation defects

People with HIV infections experience a wide range of abnormalities in their immune systems, and one of the most recently discovered abnormalities includes affinity maturation defects within the memory B cells. Read More »

Statins decreases TB treatment time in tested mice

A recent study from the Johns Hopkins University School of Medicine shows that when mice receive statins, typically used to reduce cholesterol, their tuberculosis (TB) infections heal faster than they otherwise would. Read More »

Blood test predicts chances of TB development

A new study from the South African Tuberculosis Vaccine Initiative at the University of Cape Town suggests that a simple blood test can predict a person’s chances of developing tuberculosis. Read More »

WHO receives emergency donation for MenC vaccines

The UK Department of Health recently granted the World Health Organization (WHO) an urgent donation amounting to more than 157,000 meningococcal C (MenC) meningitis and septicaemia vaccines. Read More »

Curcumin may help fight drug-resistant tuberculosis

Curcumin, which is found in turmeric and is one of the major elements in curry powder, may be able to help treat people who have infections of drug-resistant tuberculosis. Read More »

New Ebola group found in Guinea

Scientists recently discovered a new cluster of the Ebola virus in Guinea, as there were three unexplained deaths in Korokpara village, located in N’Zerekore prefecture, during the last few seeks. Read More »

New discoveries show promise for AIDS vaccine

Researchers from The Scripps Research Institute (TSRI), the International AIDS Vaccine Initiative (IAVI) and the La Jolla Institute for Allergy and Immunology recently discovered that an engineered vaccine protein bonds with important immune cells that are available in almost all humans, potentially helping create HIV antibodies naturally. Read More »

Global health community marks World Tuberculosis Day

To mark World Tuberculosis Day Thursday, the global health community honored discoveries from scientists who have made TB discoveries throughout history, including Robert Koch. Read More »

Simulation demonstrates pandemic swine flu had minor effect in Finland

Scientists recently used a simulation model to demonstrate the true effects of various infectious disease in an area, with the pandemic swine flu and its minor effects on Finland. Read More »

University of Georgia, Sanofi Pasteur researchers design new H1N1 influenza vaccine

Scientists at the University of Georgia and Sanofi Pasteur, which is the vaccines division of Sanofi, recently developed a new vaccine to protect people from H1N1 influenza. Read More »

Seasonal flu vaccine matches New Mexico strains

The New Mexico Department of Health recently confirmed that the seasonal influenza vaccine is a positive match for the strains that are currently circulating, adequately protecting people from contracting the influenza virus. Read More »

WHO director-general releases statement about Zika virus

Dr. Margaret Chan, the director-general of the World Health Organization (WHO), recently released a statement about the outbreak of the Zika virus, which has continued to be an ongoing problem since Feb. 1. Read More »

New drug combinations may expedite TB treatments

Scientists from Shanghai Jiano Tong University and UCLA have created a novel combination of drugs that could shorten the amount of time that tuberculosis patients undergo treatment. Read More »

Scientists develop alternative for Ebola screening program

A study recently published in Preventive Medicine shows a potential alternative that scientists have developed to replace the Ebola entry screen program that is in place at U.S. airports. Read More »